600064 南京高科
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,517,708-64.20%4,733,0384,490,0614,934,5272,923,501
减:营业总成本1,476,625-64.34%4,564,9614,095,9564,688,8342,621,915
    其中:营业成本1,192,205-68.88%4,143,8663,649,0473,797,9871,745,096
               财务费用162,378-2.01%220,384177,024203,312137,576
               资产减值损失346--(608,242)(2,743)(72,938)(28,714)
公允价值变动收益143,173-342.25%(140,770)(242,623)(34,410)792,231
投资收益1,724,4342.36%1,964,6752,405,3342,367,1231,462,461
    其中:对联营企业和合营企业的投资收益1,708,4749.03%1,829,7262,096,3341,686,4581,358,636
营业利润1,897,77210.08%1,367,5402,650,4142,679,0732,381,883
利润总额1,897,15310.08%1,369,9622,651,6352,679,2092,371,132
减:所得税费用44,027-0.46%(112,586)171,739276,924266,246
净利润1,853,12510.35%1,482,5492,479,8952,402,2852,104,886
减:非控股权益14,91558.96%(77,597)77,52250,23289,098
股东净利润1,838,21010.08%1,560,1462,402,3742,352,0532,015,789

市场价值指针
每股收益 (元) *1.06210.05%0.9021.3881.3591.631
每股派息 (元) *----0.2800.4200.6000.500
每股净资产 (元) *10.9848.13%10.1369.572--10.724
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容